Gene Therapy of Cancer: Activation of Nucleoside Prodrugs with E. coli Purine Nucleoside Phosphorylase
โ Scribed by Secrist, John A.; Parker, William B.; Allan, Paula W.; Bennett, L. Lee; Waud, William R.; Truss, Jackie W.; Fowler, Anita T.; Montgomery, John A.; Ealick, Steven E.; Wells, Alan H.
- Book ID
- 115315683
- Publisher
- Taylor and Francis Group
- Year
- 1999
- Tongue
- English
- Weight
- 615 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0732-8311
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Background Pancreatic cancer remains a rapidly fatal disease. Suicide gene therapy has been shown to be an effective tool for pancreatic tumor cell destruction, but a cellโspecific gene delivery is required to limit host toxicity. The objective of this study was both to design recom
## Background: Previous studies have shown that herpes simplex virus thymidine kinase (hsv-tk)/ganciclovir (gcv) comprised the most commonly used suicide gene therapy for prostate cancer, with modest results being obtained. however, novel suicide genes, such as escherichia coli purine nucleoside ph